P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer

Neurology

Volumn 59, Issue 5, 2002, Pages 764-766

  Graus, F ^a   Lang, B ^b   Pozo Rosich, P ^a   Saiz, A ^a   Casamitjana, R ^a   Vincent, A ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; HU ANTIBODY; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CALCIUM CURRENT; CHANNEL GATING; CLINICAL ARTICLE; CONTROLLED STUDY; EATON LAMBERT SYNDROME; FEMALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; NEUROPATHOLOGY; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL;

EID: 0037056395     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.5.764     Document Type: Article

References (10)

1. Dalmau J, Gultekin HS, Posner JB. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 1999;9:275-284.
2. Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997;120:1279-1300.
3. Voltz RA, Carpentier AF, Rosenfeld MR, Posner JB, Dalmau J. P/Q type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system. Muscle Nerve 1999;22:119-122.
4. Hillman D, Chen S, Aung TT, Cherksey B, Sugimori M, Llinás RR. Localization of P-type calcium channels in the central nervous system. Proc Natl Acad Sci USA 1991;88: 7076-7080.
5. Graus F, Dalmau J, Vallderiola F, et al. Immunological characterization of a neural antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997;74:55-61.
6. Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995;58: 85-87.
7. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-1474.
8. Lang B, Newsom-Davis J. Immunopathology of the Lambert-Eaton myasthenic syndrome. Springer Semin Immunopathol 1995;17:3-15.
9. Pinto A, Gillard S, Moss F, et al. Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. Proc Natl Acad Sci USA 1998;95:8328-8333.
10. Blumenfeld AM, Recht LD, Chad DA, DeGiorlami U, Griffin T, Jeackle KA. Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment. Neurology 1991;41:1682-1685.